Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Pfizer has a deep lineup and pipeline, generates consistent results, and pays dividends. Moderna is on the verge of key approvals and has exciting pipeline candidates in the works. One of these ...

Biopharma giant Pfizer Inc. (NYSE: PFE) has given back all its COVID gains and more. Shareholders have sat through a painful ...

Moderna and Pfizer are in talks with the federal government over a potential avian flu vaccine program, the head of the U.S. government’s pandemic response administration said late Wednesday.

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

Top vaccine stocks for investors to consider include Pfizer and Moderna. Other vaccine stocks to watch include Bavarian Nordic and Emergent BioSolutions. Key findings are powered by ChatGPT and ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary Kennedy's 'misinformation and lies.' ...

In fact, one wag on Twitter compared the time taken to come up with logo to the mere seven months Pfizer and BioNtech needed to bring their COVID-19 vaccine through clinical testing: https ...

A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine ...